Mahalingam, D., Patel, M. R., Sachdev, J. C., Hart, L. L., Halama, N., Ramanathan, R. K., . . . Tsimberidou, A. M. (2020). Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours. Br J Clin Pharmacol.
Stile di citazione ChicagoMahalingam, Devalingam, et al. "Phase I Study of Imalumab (BAX69), a Fully Human Recombinant Antioxidized Macrophage Migration Inhibitory Factor Antibody in Advanced Solid Tumours." Br J Clin Pharmacol 2020.
Citazione MLAMahalingam, Devalingam, et al. "Phase I Study of Imalumab (BAX69), a Fully Human Recombinant Antioxidized Macrophage Migration Inhibitory Factor Antibody in Advanced Solid Tumours." Br J Clin Pharmacol 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.